United States · FDA National Drug Code directory
Rabeprazole Sodium DR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 80425-0134_4df0b57a-090c-2350-e063-6394a90addbe
- Product NDC
- 80425-0134
- Form
- TABLET, DELAYED RELEASE
- Composition / generic term
- Rabeprazole Sodium
- Labeler
- Advanced Rx Pharmacy of Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180427
- Source listing expiry
- 20271231
Source-listed ingredients
- RABEPRAZOLE SODIUM — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, DELAYED RELEASE in 1 BOTTLE (80425-0134-1) · 80425-0134-1
- 60 TABLET, DELAYED RELEASE in 1 BOTTLE (80425-0134-2) · 80425-0134-2
- 90 TABLET, DELAYED RELEASE in 1 BOTTLE (80425-0134-3) · 80425-0134-3
- 6 TABLET, DELAYED RELEASE in 1 BOTTLE (80425-0134-4) · 80425-0134-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →